financetom
Business
financetom
/
Business
/
Trump Media (DJT) Rises 11% In Tuesday Pre-Market: What's Going On?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Trump Media (DJT) Rises 11% In Tuesday Pre-Market: What's Going On?
Nov 3, 2024 1:29 PM

Trump Media & Technology Group Corp ( DJT ) experienced a notable surge in its stock price, rising by 10.24% during pre-market trading on Tuesday. This uptick follows a campaign rally by Donald Trump in New York City. The stock had previously closed 21.59% higher at $47.36 on Monday, as per Benzinga Pro.

What Happened: The rally was held at Madison Square Garden on Sunday, where Trump aimed to challenge Democratic candidate Kamala Harris. Despite New York’s historical leaning towards Democratic presidential candidates, Trump attempted to win over voters with his message.

According to Reuters, the event began with controversial statements from Trump’s allies. Trump focused on his strategies to curb illegal immigration and deport migrants. The rally included a diverse group of speakers, such as former pro wrestler Hulk Hogan, ex-New York City Mayor Rudy Giuliani, and Trump’s sons Eric and Don Jr.

See Also: Scaramucci: Election ‘Too Close To Call’ But Expects Harris To Win And Trump To Try To Avoid Jail

Why It Matters: The recent surge in Trump Media & Technology Group’s stock highlights its unique position as a political proxy on Wall Street. Despite lacking strong financial fundamentals, the stock continues to rally, driven by Trump’s stake in the company and his commitment not to sell shares.

The company, which owns the social media platform “Truth Social,” has limited revenue streams and market presence. However, the stock’s performance reflects the influence of political events and Trump’s ongoing engagement with his base.

The election is expected to be a tight race between Trump and Harris. While election polls suggest a close contest, prediction markets are currently favoring Trump to win.

Read Next:

Trump Says Robert Kennedy Jr. Can Run Wild On Health And Food: ‘I’m Going To Let Him Go Wild On The Medicines’

Image via Shutterstock

This story was generated using Benzinga Neuro and edited by Pooja Rajkumari

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved